Condition: Gestational Diabetes · Sponsor: Anna Stanhewicz, PhD
The purpose of this investigation is to examine the mechanisms mediating vascular dysfunction in women who have had gestational diabetes and how metformin may be a valuable treatment tool to improve microvascular function in these women before the onset of disease.
This description comes directly from the study's public registry record.
Anna Stanhewicz, PhD · 3194671732 · anna-stanhewicz@uiowa.edu
Always discuss trial participation with your own doctor first.
| University of Iowa | Iowa City, Iowa, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05917587